Relay Therapeutics, Inc.
RLAY
Classement en actions
#4015
Relay Therapeutics, Inc. is a precision medicine company currently engaged in... Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. The company's pipeline features several promising drug candidates: RLY-4008, an orally administered small molecule designed to inhibit fibroblast growth factor receptor 2 (FGFR2), which is undergoing its initial human trials for patients with advanced or metastatic solid tumors exhibiting FGFR2 alterations; RLY-2608, a leading program targeting mutant phosphoinositide 3 kinase alpha (PI3Ka); and RLY-1971, another oral small molecule, an inhibitor of SHP2 (protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2), currently in Phase 1 trials for individuals with advanced solid tumors. Relay Therapeutics has established strategic partnerships, including a collaboration with D. E. Shaw Research, LLC, which utilizes computational modeling to analyze protein motion for the identification and development of therapeutic compounds. Furthermore, an agreement with Genentech, Inc. supports the development and commercialization of RLY-1971. Founded in 2015 as Allostery, Inc., the company rebranded to Relay Therapeutics, Inc. in December of that year and maintains its headquarters in Cambridge, Massachusetts.
Prix de l'action
$18.65
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$4.09B
Changement (1 jour)
9.15%
Changement (1 an)
164.96%
Pays
US
Échange Relay Therapeutics, Inc. (RLAY)
Catégorie
Healthcare
Historique des divisions d’actions pour Relay Therapeutics, Inc. (RLAY)
L’action Relay Therapeutics, Inc. (symbole : RLAY) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action RLAY achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions RLAY.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action RLAY achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions RLAY.
Liste des divisions d’actions
| Année | Division | Multiplicateur | Multiplicateur cumulatif |
|---|---|---|---|
| Pas assez de données pour les dates fournies. | |||
Divisions d’actions d’entreprises similaires ou concurrentes
| Entreprise | Nombre de divisions d’actions | Multiplicateur cumulatif | Pays |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
